Hilde Stubdal

Hilde Stubdal has extensive experience in the life sciences industry, with a focus on oncology and immuno-oncology. From January 2018 to January 2019, Hilde served as Executive Director at Pfizer, leading Worldwide Business Development for both Oncology Search & Evaluation and External Science. Prior experience includes a role as Principal at BioAssess LLC from January 2013 to January 2018, where responsibilities encompassed in-licensing and out-licensing, scientific evaluation, due diligence, and deal negotiation. Additionally, Hilde was involved in Corporate Development, Licensing, and M&A at Onyx Pharmaceuticals from January 2008 to December 2013, and served as a Senior Scientist at Cerus Corporation from January 2004 to January 2007. Hilde holds a B.Sc. in Biochemistry from Brown University and both a Ph.D. in Medical Sciences (Virology) and an MMSc. in Master of Medical Sciences from Harvard University.